GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Price-to-Owner-Earnings

Abbott India (BOM:500488) Price-to-Owner-Earnings : 42.19 (As of Jun. 07, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Price-to-Owner-Earnings?

As of today (2024-06-07), Abbott India's share price is ₹27505.60. Abbott India's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹651.93. It's Price-to-Owner-Earnings for today is 42.19.


The historical rank and industry rank for Abbott India's Price-to-Owner-Earnings or its related term are showing as below:

BOM:500488' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 25.05   Med: 45.21   Max: 72.06
Current: 39.69

During the past 13 years, the highest Price-to-Owner-Earnings of Abbott India was 72.06. The lowest was 25.05. And the median was 45.21.


BOM:500488's Price-to-Owner-Earnings is ranked worse than
70.14% of 422 companies
in the Drug Manufacturers industry
Industry Median: 25.585 vs BOM:500488: 39.69

As of today (2024-06-07), Abbott India's share price is ₹27505.60. Abbott India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹565.28. Therefore, Abbott India's PE Ratio for today is 48.66.

As of today (2024-06-07), Abbott India's share price is ₹27505.60. Abbott India's EPS without NRI for the trailing twelve months (TTM) ended in was ₹565.28. Therefore, Abbott India's PE Ratio without NRI for today is 48.66.

During the past 13 years, Abbott India's highest PE Ratio without NRI was 73.84. The lowest was 17.92. And the median was 44.86.


Abbott India Price-to-Owner-Earnings Historical Data

The historical data trend for Abbott India's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Price-to-Owner-Earnings Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.10 42.49 38.08 45.50 41.33

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.50 - - - 41.33

Competitive Comparison of Abbott India's Price-to-Owner-Earnings

For the Drug Manufacturers - General subindustry, Abbott India's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Abbott India's Price-to-Owner-Earnings falls into.



Abbott India Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Abbott India's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=27505.60/651.93
=42.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (BOM:500488) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Abbott India Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Abbott India's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines